News & Updates
Filter by Specialty:
Symptomatic COVID-19 at pregnancy end tied to increased complications in mothers, infants
Expectant mothers with symptomatic COVID-19 upon hospital admission for delivery had a higher risk of emergency complications surrounding delivery, according to a small retrospective study from the US presented at Anesthesiology 2021. Furthermore, infants born to symptomatic mothers were more likely to require intensive care unit (ICU) admission or respiratory support.
Symptomatic COVID-19 at pregnancy end tied to increased complications in mothers, infants
12 Nov 2021
Antiseizure drug yields durable seizure frequency reduction, lowers concomitant medication burden
In the treatment of adults with uncontrolled focal seizures, the long-term, open-label use of cenobamate appears to produce high rates of sustained 100-percent and ≥90-percent seizure reduction, with parallel decreases in concomitant antiseizure medication (ASM) doses, according to two separate post hoc analyses of a phase III C021 trial.
Antiseizure drug yields durable seizure frequency reduction, lowers concomitant medication burden
12 Nov 2021
Metabolic dysfunction-associated fatty liver disease ups risk of severe COVID-19
Metabolic dysfunction-associated fatty liver disease (MAFLD) can escalate the incidence of severe COVID-19, but no association between MAFLD and COVID-19 death has been confirmed, suggest the results of a meta-analysis.
Metabolic dysfunction-associated fatty liver disease ups risk of severe COVID-19
12 Nov 2021
Maintenance with ABC/3TC + RPV sustains virological suppression in HIV-1
Switching to abacavir/lamivudine plus rilpivirine (ABC/3TC + RPV) for maintenance therapy is a safe and effective option for patients with virologically suppressed HIV-1, according to a recent Singapore study.
